186,272 Shares in Intra-Cellular Therapies, Inc. (NASDAQ:ITC

Parkman Healthcare Partners LLC acquired a new position in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) in the fourth quarter, Holdings Channel reports. The institutional investor acquired 186,272 shares of the biopharmaceutical company’s stock, valued at approximately $13,341,000. Intra-Cellular Therapies comprises about 1.9% of Parkman Healthcare Partners LLC’s portfolio, making the stock its […]

Related Keywords

Canada , United States , America , Robertw Baird , , Nasdaq , Regal Investment Advisors , Holdings Channel , Cellular Therapies Company Profile , Avoro Capital Advisors , Royal Bank , Eagle Asset Management Inc , Parkman Healthcare Partners , Cellular Therapies Inc , Schroder Investment Management Group , Needham Company , Lighthouse Investment Partners , Intra Cellular Therapies , Free Report , Cellular Therapies , Capital Advisors , Investment Partners , Investment Advisors , Investment Management Group , Eagle Asset Management , Asset Management , Get Free Report , Visit Holdingschannel , Intra Cellular Therapies Daily ,